According to a recent leak, the Chronicled Banner is coming back to Genshin Impact, and the timing of its return bears some ...

GSK has revised its annual vaccine sales forecast following new guidance on RSV from the CDC. But new evidence offers new ...

Wolff Olins has created the new brand identity for global healthcare company GSK (formerly GlaxoSmithKline), aiming to better express its focus on innovation. The agency was brought on board around 18 ...

GSK plc GSK announced positive topline results from a phase III study evaluating the co-administration of its two marketed ...

After several years of anticipation, it’s a new GSK. And so far, the results look pretty good. The company, with facilities in Collegeville and Valley Forge, reported positive second quarter ...

British drugmaker GSK said on Wednesday it had agreed to settle two lawsuits in California that claimed its discontinued ...

Questions remain about GSK’s ability to come up with new drugs and litigation over the antacid Zantac, and the stock still ...

GlaxoSmithKline (GSK ... s pay will be determined following the consultations and will be 'in line with the new policy'. Her base salary will be set on her appointment to the board on 1 January ...

The Banner 9 environment is now available to all current Banner users. We are encouraging all current Banner users to learn about the new user interface and navigation functionality prior to accessing ...

GSK’s twice-yearly depemokimab reduced asthma attacks by half and cut clinic visits by nearly three-quarters, positioning it ...

GSK's severe asthma therapy Nucala could find a new lease of life as a treatment for chronic obstructive pulmonary disease (COPD) after showing a clear benefit in a phase 3 trial. The headline ...

GlaxoSmithKline (NYSE:GSK) hit a new 52-week high Tuesday as it is currently trading at $53.61, above its previous 52-week high of $53.45 with 1.2 million shares traded as of 12:05 p.m. ET.